Clorox Co (NYSE:CLX)‘s stock had its “hold” rating reaffirmed by equities researchers at Jefferies Group LLC in a research note issued on Friday. They currently have a $132.00 price objective on the stock. Jefferies Group LLC’s price target would indicate a potential upside of 2.36% from the company’s previous close.
CLX has been the subject of a number of other reports. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price target on shares of Clorox in a research note on Wednesday, August 2nd. Zacks Investment Research downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub downgraded Clorox from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox in a research note on Tuesday, September 12th. Finally, Barclays PLC reiterated an “equal weight” rating and set a $136.00 price objective (down from $140.00) on shares of Clorox in a research note on Friday, August 4th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Clorox presently has a consensus rating of “Hold” and an average price target of $127.39.
Clorox (NYSE CLX) opened at 128.96 on Friday. The company has a market cap of $16.64 billion, a price-to-earnings ratio of 24.17 and a beta of 0.39. Clorox has a 52-week low of $111.24 and a 52-week high of $141.76. The company’s 50-day moving average is $134.82 and its 200 day moving average is $134.67.
Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox had a return on equity of 171.29% and a net margin of 12.26%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.30 EPS. Equities analysts forecast that Clorox will post $5.66 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This article was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2017/10/06/clorox-co-clx-receives-hold-rating-from-jefferies-group-llc.html.
In other news, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. Insiders have sold a total of 21,242 shares of company stock worth $2,944,449 over the last ninety days. Insiders own 1.00% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of CLX. BlackRock Inc. raised its holdings in shares of Clorox by 1,402.2% during the 1st quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after acquiring an additional 9,698,542 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Clorox by 8,008.5% during the 2nd quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after acquiring an additional 1,307,153 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Clorox by 4.8% during the 1st quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after acquiring an additional 649,766 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Clorox by 24.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after acquiring an additional 265,200 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of Clorox by 24.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after acquiring an additional 263,700 shares in the last quarter. 71.33% of the stock is currently owned by institutional investors and hedge funds.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co and related companies with MarketBeat.com's FREE daily email newsletter.